The landscape of dementia analysis has progressed radically with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-based assessments that can detect Alzheimer's pathology a long time before signs emerge. Though these technological innovations stand for impressive progress in comprehending neurodegenerative